Rare diseases
Investigational molecules
Locations
Back to France3 332 clinical trials in Corbeil Essonnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors
FranceStudy on Asthma Control and Adherence with Mepolizumab in Pre-filled Devices for Patients with Asthma
FranceStudy on Long-term Effects and Safety of Odevixibat in Children with Biliary Atresia
FranceStudy on the Effects of EDG-5506 for Adults and Adolescents with Becker Muscular Dystrophy
FranceStudy of BGB-A425, LBL-007, and Tislelizumab for Patients with Advanced Head and Neck Cancer, Lung Cancer, or Kidney Cancer
FranceStudy on Adding Ipilimumab to Atezolizumab and Bevacizumab for Patients with Liver Cancer Receiving First-Line Treatment
FranceStudy on Botensilimab and Balstilimab for Patients with Advanced Melanoma Resistant to Previous Treatments
FranceStudy on the Effects of JNJ-63733657 and Florquinitau F18 in Patients with Early Alzheimer's Disease
FranceStudy Comparing Pembrolizumab and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma
FranceLong-term Safety Study of Daratumumab with Drug Combination for Patients with Multiple Myeloma or Smoldering Multiple Myeloma
FranceStudy on Antiviral Therapy with Nirmatrelvir and Remdesivir for Immunocompromised COVID-19 Patients
FranceStudy on the Impact of Sufentanil Citrate and Remifentanil on Heart Rate During Rapid Sequence Intubation in Patients Over 55 with High Anesthesia Risk
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on novel treatments for Type 1 and Type 2 Diabetes, particularly investigating therapies like tirzepatide for glycemic control and cardiovascular outcomes in patients with obesity and diabetes.
Groundbreaking trials in Multiple Myeloma treatment, evaluating combinations of targeted therapies including elranatamab, lenalidomide, and daratumumab for newly diagnosed and relapsed cases.
Research examining innovative treatments for Immune Thrombocytopenia, Polymyalgia Rheumatica, and Lupus Nephritis, focusing on targeted therapies and steroid-sparing approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
